[go: up one dir, main page]

FI844199L - Laekemedelspreparat. - Google Patents

Laekemedelspreparat.

Info

Publication number
FI844199L
FI844199L FI844199A FI844199A FI844199L FI 844199 L FI844199 L FI 844199L FI 844199 A FI844199 A FI 844199A FI 844199 A FI844199 A FI 844199A FI 844199 L FI844199 L FI 844199L
Authority
FI
Finland
Prior art keywords
laekemedelspreparat
Prior art date
Application number
FI844199A
Other languages
English (en)
Other versions
FI844199A7 (fi
FI844199A0 (fi
Inventor
Peter Serno
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI844199A0 publication Critical patent/FI844199A0/fi
Publication of FI844199A7 publication Critical patent/FI844199A7/fi
Publication of FI844199L publication Critical patent/FI844199L/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
FI844199A 1983-10-28 1984-10-25 Laekemedelspreparat. FI844199L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833339236 DE3339236A1 (de) 1983-10-28 1983-10-28 Arzneimittelzubereitung

Publications (3)

Publication Number Publication Date
FI844199A0 FI844199A0 (fi) 1984-10-25
FI844199A7 FI844199A7 (fi) 1985-04-29
FI844199L true FI844199L (fi) 1985-04-29

Family

ID=6213011

Family Applications (1)

Application Number Title Priority Date Filing Date
FI844199A FI844199L (fi) 1983-10-28 1984-10-25 Laekemedelspreparat.

Country Status (14)

Country Link
US (1) US4711902A (fi)
EP (1) EP0143305A1 (fi)
JP (1) JPS60115517A (fi)
KR (1) KR850002953A (fi)
AU (1) AU3358784A (fi)
DE (1) DE3339236A1 (fi)
DK (1) DK510384A (fi)
ES (1) ES8604419A1 (fi)
FI (1) FI844199L (fi)
GR (1) GR80788B (fi)
HU (1) HU193908B (fi)
IL (1) IL73318A (fi)
NO (1) NO844144L (fi)
ZA (1) ZA848375B (fi)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3515335C2 (de) * 1985-04-27 1995-01-26 Bayer Ag Arzneizubereitung enthaltend Dihydropyridine und Verfahren zu ihrer Herstellung
DE3624624A1 (de) * 1986-07-18 1988-01-28 Asche Ag Xylometazolinhaltige pharmazeutische praeparate
DE3626908A1 (de) * 1986-08-08 1988-02-11 Bayer Ag Parenterale loesung
JPS6348214A (ja) * 1986-08-18 1988-02-29 Morishita Seiyaku Kk 1−〔2−(2,4−ジクロロフエニル)−3−メチル−1−ペンテニル〕−1h−イミダゾ−ルを含有する水中油型脂肪乳剤
ATE68704T1 (de) * 1986-12-18 1991-11-15 Bauer Kurt Heinz Gegenueber lichteinfluss stabilisiertes nifedipin- konzentrat und verfahren zu seiner herstellung.
FR2609714A1 (fr) * 1987-01-15 1988-07-22 Sanofi Sa Compositions liquides stables a base de derives antifongiques imidazoles
US4895876A (en) * 1987-03-20 1990-01-23 Air Products And Chemicals, Inc. Concentrated stable fluorochemical aqueous emulsions containing triglycerides
ES2033086T3 (es) * 1988-01-29 1993-03-01 Sankyo Company Limited Un procedimiento para la preparacion de una composicion farmaceutica.
HU201567B (en) * 1988-07-21 1990-11-28 Gyogyszerkutato Intezet Process for production of intravenous medical compositions containing cyclosphorin
JPH02184633A (ja) * 1988-11-23 1990-07-19 Abbott Lab エイズ治療剤
CA2011063C (en) * 1989-02-28 1999-07-06 Calum B. Macfarlane Nicardipine pharmaceutical composition for parenteral administration
JP2732918B2 (ja) * 1989-10-31 1998-03-30 ライオン株式会社 口腔清浄剤組成物
JP3074731B2 (ja) * 1989-12-01 2000-08-07 日本新薬株式会社 脂肪乳剤
WO1991007964A1 (fr) * 1989-12-01 1991-06-13 Nippon Shinyaku Co., Ltd. Emulsion de graisse
TW211015B (fi) * 1990-01-11 1993-08-11 Nippon Shinyaku Co Ltd
US5534502A (en) * 1990-11-06 1996-07-09 Nippon Shinyaku Co. Ltd. Process for producing fat emulsion
EP0556392A4 (en) * 1990-11-06 1994-03-17 Nippon Shinyaku Co Ltd PROCESS FOR PRODUCING A FATTY EMULSION.
CA2108266C (en) * 1991-04-19 2003-06-03 Albert J. Owen Convertible microemulsion formulations
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
SE9303744D0 (sv) * 1993-11-12 1993-11-12 Astra Ab Pharmaceutical emulsion
ES2206473T3 (es) * 1994-05-20 2004-05-16 Gesellschaft Fur Medizinische Forschung Und Weiterbildung E.V. Gmf Emulsion de aceite en agua que contiene lormetazepam.
US7205279B2 (en) * 1995-10-25 2007-04-17 Novartis Ag Pharmaceutical compositions
US5616342A (en) * 1995-04-11 1997-04-01 Pdt, Inc. Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof
US5858401A (en) * 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
IL141095A0 (en) 1998-08-19 2002-02-10 Rtp Pharma Inc Injectable aqueous dispersions of propofol
US6720001B2 (en) 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
AU2001285076A1 (en) * 2000-08-17 2002-02-25 Apollo Biopharmaceutics Inc. Formulation for administering therapeutic lipophilic molecules
US8460693B2 (en) * 2001-11-08 2013-06-11 Atrium Medical Corporation Intraluminal device with a coating containing synthetic fish oil and a therapeutic agent
KR100848755B1 (ko) * 2002-01-02 2008-07-25 주식회사 두산 포스파티딜세린 함유 액상 조성물 및 그 제조방법
PT1509492E (pt) * 2002-01-25 2011-11-21 Theravance Inc Agentes hipnóticos sedativos de actuação rápida para anestesia e sedação
US6979672B2 (en) 2002-12-20 2005-12-27 Polichem, S.A. Cyclosporin-based pharmaceutical compositions
SI1648413T1 (sl) * 2003-07-23 2010-01-29 Theravance Inc Farmacevtski sestavki kratko delujočega sedativnega hipnotičnega sredstva
WO2007011385A2 (en) 2004-09-28 2007-01-25 Atrium Medical Corporation Heat cured gel and method of making
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
BRPI0500520A (pt) * 2005-02-16 2006-09-26 Henry Jun Suzuki uso de agentes flavorizantes aromáticos de alto ponto de fusão como agentes solubilizantes ou inibidores de cristalização em composições farmacêuticas
BRPI0501120A (pt) * 2005-02-18 2006-10-03 Henry Jun Suzuki composições farmacêuticas orais e parenterais contendo altas concentrações de agentes solubilizantes aromáticos
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
CA2649779A1 (en) 2006-04-18 2007-10-25 Ekr Therapeutics, Inc. Pre-mixed, ready-to-use iv bolus compositions and methods of use
US9416065B2 (en) * 2007-02-12 2016-08-16 Archer Daniels Midland Company Adjuvants and methods of using them
DE102007058785B3 (de) * 2007-12-06 2009-08-20 Hewitech Gmbh & Co. Kg Zusammensteckbare Entwässerungs- und/oder Drainagevorrichtung
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
EP2571489B1 (en) * 2010-05-13 2014-08-06 AstraZeneca AB Injectable emulsion of sedative hypnotic agent
WO2012009707A2 (en) 2010-07-16 2012-01-19 Atrium Medical Corporation Composition and methods for altering the rate of hydrolysis of cured oil-based materials
KR102009698B1 (ko) 2011-12-20 2019-08-13 바이옴 테라퓨틱스 리미티드 진균 감염의 치료를 위한 국소 오일 조성물
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
AU2014252157B2 (en) * 2013-04-12 2017-05-11 Vyome Therapeutics Limited Composition and formulation of antimicrobial agents, processes thereof and methods for treating microbial infections
CN104622806B (zh) * 2015-02-04 2018-03-16 北京蓝丹医药科技有限公司 一种丙泮尼地药物组合物及其制备方法
WO2025182623A1 (ja) * 2024-02-28 2025-09-04 テクノガード株式会社 水および油難溶性薬物含有乳剤およびその製造方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE592881C (de) * 1932-03-27 1934-02-16 Carl Weill Dr Verfahren zur Herstellung haltbarer, fuer Injektionszwecke geeigneter Emulsionen vonin Wasser unloeslichen oder schwer loeslichen Arzneimitteln
US3149037A (en) * 1962-09-07 1964-09-15 Hoffmann La Roche Vitamin compositions
DE1792410B2 (de) * 1967-09-01 1980-03-13 Apoteksvarucentralen Vitrum Apotekareaktiebolaget, Stockholm Arzneimittelzubereitung zur intravenösen Injektion
DE1963188A1 (de) * 1969-12-17 1971-06-24 Bayer Ag Neue Cyanphenyl-1,4-dihydropyridinderivate
DE2815578C2 (de) * 1978-04-11 1986-01-16 Bayer Ag, 5090 Leverkusen Neue pharmazeutische Verwendung von Nimodipin
SE429652B (sv) * 1978-06-30 1983-09-19 Haessle Ab 2.6-dimetyl-4-(2.3-diklorfenyl)-1.4-dihydropyridin-3.5-dikarboxylsyra-3-metylester-5-etylester
DE2837477A1 (de) * 1978-08-28 1980-03-13 Bayer Ag Sila-substituierte 1,4-dihydropyridin- derivate
DE2935573A1 (de) * 1979-09-03 1981-03-19 Lepharm- Pharmazeutische Entwicklungs- und Vertriebsgesellschaft GmbH, 5000 Köln Infusionsloesungen mit mono- und diglyceriden von fettsaeuren
JPS5665820A (en) * 1979-11-02 1981-06-03 Eisai Co Ltd Hard capsule with high content of tocopherol nicotinate
DE3106635A1 (de) * 1981-02-23 1982-09-09 Bayer Ag Antimykotisches mittel mit hoher wirkstoff-freisetzung in form von stiften

Also Published As

Publication number Publication date
HUT36703A (en) 1985-10-28
EP0143305A1 (de) 1985-06-05
JPS60115517A (ja) 1985-06-22
ZA848375B (en) 1985-06-26
ES537022A0 (es) 1986-02-01
FI844199A7 (fi) 1985-04-29
ES8604419A1 (es) 1986-02-01
NO844144L (no) 1985-04-29
AU3358784A (en) 1985-05-02
US4711902A (en) 1987-12-08
GR80788B (en) 1985-02-20
KR850002953A (ko) 1985-05-28
HU193908B (en) 1987-12-28
FI844199A0 (fi) 1984-10-25
IL73318A (en) 1988-06-30
DE3339236A1 (de) 1985-05-09
IL73318A0 (en) 1985-01-31
DK510384D0 (da) 1984-10-25
DK510384A (da) 1985-04-29

Similar Documents

Publication Publication Date Title
DE3484505D1 (de) Immuntest.
ATE99311T1 (de) Carboxyalkenamidocephalosporine.
EP0136362A4 (en) Biosensor.
FI830256L (fi) Silplaot.
DE3483306D1 (de) Mikrorechner.
FI81916B (fi) Foer straolning kaenslig skiva.
FI844199A0 (fi) Laekemedelspreparat.
FI830012L (fi) Roerbandtransportoer.
DE3482323D1 (de) Benzopyranisomere.
DE3484698D1 (de) Antitumormittel.
DE3480652D1 (de) Benzocycloalkanderivate.
DE3485948D1 (de) Hepatitis-a-untereinheit-antigen.
FI830043L (fi) Mjukvaevnadsfilteranordning.
FI830016L (fi) Haolskiva foer en inloppslaoda foer en pappersmaskin.
FI843768A0 (fi) Vaermekaensliga bandmaterial.
DE3484095D1 (de) Transformatorlose gegentaktendstufe.
DE3483137D1 (de) Ec-torfeld.
FI830202L (fi) Hugg.
DE3485726D1 (de) Mikropozessor.
FI841317A0 (fi) Elvaermare.
FI830108L (fi) Dubbningsmaskin.
ES269570Y (es) Muneco-esquiador.
ES272051Y (es) Roto-subsolador.
ES271443Y (es) Tapon-precinto.
ES270608Y (es) Trifiltro.

Legal Events

Date Code Title Description
FA Application withdrawn [patent]

Owner name: BAYER AKTIENGESELLSCHAFT